Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients.
PS3-16: Access and Collaboration with the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH).
Vitamin D immunomodulatory potential in multiple sclerosis.
Faith as a resource in patients with multiple sclerosis is associated with a positive interpretation of illness and experience of gratitude/awe.
Efficacy of A Telephone-Delivered Self-Management Intervention For Persons With Multiple Sclerosis: a Randomized Controlled Trial With a One-Year Follow-Up.
Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
Effects of albendazole combined with TSII-A (a Chinese herb compound) on optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice.
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
In vivo quantitative whole-brain T1 rho MRI of multiple sclerosis.
Pathological Involvement of Astrocyte-Derived Lipocalin-2 in the Demyelinating Optic Neuritis.
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.
Clinical manifestations of neuromyelitis optica in male and female patients.
Assessment of upper extremity function in multiple sclerosis: review and opinion.
Does long term treatment with azathioprine predispose to malignancy and death in patients with systemic lupus erythematosus?
Lynoral: How To Order
A peptide nucleic acid (PNA)-mediated polymerase chain reaction clamping allows the selective inhibition of the ERVWE1 gene amplification.
GM-CSF-Neuroantigen Fusion Proteins Reverse Experimental Autoimmune Encephalomyelitis and Mediate Tolerogenic Activity in Adjuvant-Primed Environments: Association with Inflammation-Dependent, Inhibitory Antigen Presentation.
What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Mesenchymal stem cells are mobilized from the bone marrow during inflammation.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
TRO19622 Promotes Myelin Repair in a rat Model of Demyelination.
[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs].
A nine-year population-based cohort study on the risk of multiple sclerosis in patients with optic neuritis.
Pages
« first
‹ previous
…
399
400
401
402
403
404
405
406
407
…
next ›
last »